Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Falciparum Malaria”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Testing effectiveness (Phase 2)Study completedNCT00362050
What this trial is testing

RBx11160 Phase II Dose Ranging Study RBx/MMV05-06

Who this might be right for
Plasmodium Falciparum Malaria
Medicines for Malaria Venture 255
Testing effectiveness (Phase 2)Study completedNCT00459615
What this trial is testing

Phase II Dose Ranging Study of Artesunate

Who this might be right for
Falciparum MalariaUncomplicated Malaria
U.S. Army Office of the Surgeon General 120
Large-scale testing (Phase 3)Study completedNCT00541385
What this trial is testing

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

Who this might be right for
Malaria
Medicines for Malaria Venture 535
Large-scale testing (Phase 3)UnknownNCT04251351
What this trial is testing

Effect of Paracetamol on Kidney Function in Severe Malaria

Who this might be right for
Severe MalariaMalaria,FalciparumAcute Kidney Injury+1 more
University of British Columbia 460
Testing effectiveness (Phase 2)Study completedNCT01753323
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT04709692
What this trial is testing

Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria

Who this might be right for
Malaria, FalciparumMalaria, Vivax
R. Kiplin Guy 22
Large-scale testing (Phase 3)Study completedNCT00709969
What this trial is testing

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis 310
Testing effectiveness (Phase 2)Study completedNCT00299208
What this trial is testing

Azithromycin Combination Therapy for Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)WithdrawnNCT01002183
What this trial is testing

Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate

Who this might be right for
Malaria
Jomaa Pharma GmbH 40
Large-scale testing (Phase 3)Study completedNCT00386763
What this trial is testing

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Who this might be right for
MalariaFalciparum
Novartis 890
Large-scale testing (Phase 3)Study completedNCT00403260
What this trial is testing

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

Who this might be right for
Falciparum Malaria
Medicines for Malaria Venture 1,271
Testing effectiveness (Phase 2)Study completedNCT01836458
What this trial is testing

Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection

Who this might be right for
Malaria
Novartis Pharmaceuticals 25
Post-approval studies (Phase 4)Study completedNCT00233337
What this trial is testing

Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

Who this might be right for
Acute Uncomplicated P. Falciparum Malaria
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT02612545
What this trial is testing

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

Who this might be right for
Acute Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 216
Testing effectiveness (Phase 2)Ended earlyNCT02880241
What this trial is testing

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Not applicableStudy completedNCT01936766
What this trial is testing

Optimal Fluid Management in Adult Severe Malaria

Who this might be right for
MalariaSepsis
University of Oxford 156
Testing effectiveness (Phase 2)Study completedNCT01594931
What this trial is testing

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Medicines for Malaria Venture 477
Large-scale testing (Phase 3)Study completedNCT00371735
What this trial is testing

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 900
Not applicableStudy completedNCT00157833
What this trial is testing

Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Who this might be right for
Falciparum MalariaVivax Malaria
Menzies School of Health Research 750
Testing effectiveness (Phase 2)Study completedNCT01464138
What this trial is testing

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children

Who this might be right for
Malaria
Jomaa Pharma GmbH 52
Load More Results